Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

Nubia Muñóz, Ricardo Manalastas, Punee Pitisuttithum, Damrong Tresukosol, Joseph Monsonégo, Kevin A. Ault, Christine Clavel, Joaquín Luna, Evan R. Myers, Sara Hood,

The Lancet · 2009 · 480 citations · 15 references

Concepts

References

15